Marla C. Dubinsky

Active 2000–2025

Also published as
Marla C Dubinsky
216
Papers
37,351
Citations
90
h-index
203
i10-index

Citations

Citations per year for Marla C. Dubinsky1990: 1 citations1991: 1 citations1994: 1 citations2000: 2 citations2001: 13 citations2002: 17 citations2003: 18 citations2004: 32 citations2005: 56 citations2006: 73 citations2007: 86 citations2008: 67 citations2009: 70 citations2010: 106 citations2011: 235 citations2012: 334 citations2013: 446 citations2014: 464 citations2015: 421 citations2016: 428 citations2017: 441 citations2018: 371 citations2019: 1,255 citations2020: 1,469 citations2021: 1,493 citations2022: 1,318 citations2023: 1,094 citations2024: 1,844 citations2025: 981 citations2026: 23 citations1992–1993: no citations, so these years are not shown1995–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,082 citing papers, 22.2% of this breakdownUnited Kingdom: 1,528 citing papers, 8.3% of this breakdownChina: 1,449 citing papers, 7.9% of this breakdownCanada: 1,030 citing papers, 5.6% of this breakdownGermany: 966 citing papers, 5.3% of this breakdownItaly: 868 citing papers, 4.7% of this breakdownFrance: 800 citing papers, 4.3% of this breakdownNetherlands: 729 citing papers, 4% of this breakdownAustralia: 518 citing papers, 2.8% of this breakdownSpain: 491 citing papers, 2.7% of this breakdownJapan: 491 citing papers, 2.7% of this breakdownBelgium: 458 citing papers, 2.5% of this breakdown
0%22.2%Other 27%

Fields

  • Biochemistry, Genetics and Molecular Biology56.6%
  • Medicine28.3%
  • Immunology and Microbiology9.3%
  • Nursing1%
  • Agricultural and Biological Sciences1%
  • Neuroscience0.9%
  • Other2.9%

Topics

  • Inflammatory Bowel Disease14.7%
  • Gut microbiota and health6.8%
  • Microscopic Colitis4.5%
  • Clostridium difficile and Clostridium perfringens research2.3%
  • Pregnancy and Medication Impact1.9%
  • Rheumatoid Arthritis Research and Therapies1.8%
  • Other68%

Coauthors

All papers

Open in search
  1. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabrielle Boucher, Stephan Brand, Carsten Büning, Ariella Cohain, Sven Cichon, Mauro D’Amato, Dirk de Jong, Kathy L. Devaney, Marla C. Dubinsky, Cathryn Edwards, David Ellinghaus, Lynnette Ferguson, Denis Franchimont, Karin Fransén, Richard B. Gearry, Michel Georges, Christian Gieger, Jürgen Glas, Talin Haritunians, Ailsa Hart, Chris Hawkey, Matija Hedl, Xinli Hu, Tom H. Karlsen, Limas Kupčinskas, Subra Kugathasan, Anna Latiano, Debby Laukens, Ian C. Lawrance, Charlie W. Lees, Édouard Louis, Gillian Mahy, John Mansfield, Angharad R. Morgan, Craig Mowat, William G. Newman, Orazio Palmieri, Cyriel Y. Ponsioen, Uroš Potočnik, Natalie J. Prescott, Miguel Regueiro, Jerome I. Rotter, Richard K. Russell, Jeremy Sanderson, Miquel Sans, Jack Satsangi, Stefan Schreiber, Lisa A. Simms, Jurgita Šventoraitytė, Stephan R. Targan, Kent D. Taylor, Mark Tremelling, Hein W. Verspaget, Martine De Vos, Cisca Wijmenga, David C. Wilson, Juliane Winkelmann, Ramnik J. Xavier, Sebastian Zeißig, Bin Zhang, Hu Zhang, Hongyu Zhao, Mark S. Silverberg, Vito Annese, Håkon Håkonarson, Steven R. Brant, Graham Radford‐Smith, Christopher G. Mathew, John D. Rioux, Eric E. Schadt and 6 more - Nature 2012 cited by 4,917

  2. Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ephraim Kenigsberg - Cell 2019 cited by 918

  3. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2023 cited by 333

  4. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Ferrante - The Lancet 2022 cited by 387

  5. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Immunity 2019 cited by 549

  6. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 cited by 1,838

  7. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 317

  8. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geert D’Haens - The Lancet 2022 cited by 316

  9. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cisca Wijmenga, Robert N. Baldassano, Murray L. Barclay, Theodore M. Bayless, Stephan Brand, Carsten Büning, Albert Cohen, J F. Colombel, Mario Cottone, Laura Stronati, Ted Denson, Martine De Vos, R. D’Incà, Marla C. Dubinsky, Cathryn Edwards, Tim Florin, Denis Franchimont, Richard B. Gearry, Jürgen Glas, A. Van Gossum, Stephen L. Guthery, Jonas Halfvarson, Hein W. Verspaget, Jean‐Pierre Hugot, Amir Karban, Debby Laukens, Ian C. Lawrance, Marc Lémann, Arie Levine, Cécile Libioulle, Édouard Louis, Craig Mowat, William G. Newman, Julián Panés, Anne Phillips, Deborah D. Proctor, Miguel Regueiro, Richard K. Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, Frank Seibold, A. Hillary Steinhart, Pieter Stokkers, Leif Törkvist, Gerd A. Kullak‐Ublick, David C. Wilson, Thomas D. Walters, Stephan R. Targan, Steven R. Brant, John D. Rioux, Mauro D’Amato, Rinse K. Weersma, Subra Kugathasan, Anne M. Griffiths, John Mansfield, Séverine Vermeire, Richard H. Duerr, Mark S. Silverberg, Jack Satsangi, Stefan Schreiber, Judy H. Cho, Vito Annese, Håkon Håkonarson, Mark J. Daly, Miles Parkes - Nature Genetics 2010 cited by 2,581

  10. Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis

    Authors: , , , , , , , , , , , , , , - Science 2012 cited by 1,085

  11. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marla C. Dubinsky, Alexander J. Greenstein, Zoë S. Gottlieb, Peter Legnani, James George, Haritz Irizar, Aleksandar Stojmirović, Carrie Brodmerkel, Andrew Kasarkis, Bruce E. Sands, Gláucia C. Furtado, Sérgio A. Lira, Zewen Kelvin Tuong, Huaibin M. Ko, Andrea Cerutti, Charles O. Elson, Menna R. Clatworthy, Miriam Mérad, Mayte Suárez‐Fariñas, Carmen Argmann, Jason A. Hackney, Gabriel D. Victora, Gwendalyn J. Randolph, Ephraim Kenigsberg, Jean‐Frédéric Colombel, Saurabh Mehandru - Nature Medicine 2022 cited by 241

  12. Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

    Authors: , , , , , , , , - Gastroenterology 2020 cited by 296

  13. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Ziring, Bruce C. Trapnell, Francisco Sylvester, Michael C. Stephens, Robert N. Baldassano, James Markowitz, Judy H. Cho, Ramnik J. Xavier, Curtis Huttenhower, Bruce J. Aronow, Greg Gibson, Jeffrey S. Hyams, Marla C. Dubinsky - The Lancet 2017 cited by 645

  14. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrea E. van der Meulen‐de Jong, Rinse K. Weersma, David C. Wilson, Miles Parkes, Séverine Vermeire, John D. Rioux, John Mansfield, Mark S. Silverberg, Graham Radford‐Smith, Dermot McGovern, Jeffrey C. Barrett, Charlie W. Lees - The Lancet 2015 cited by 778

  15. Defining Transabdominal Intestinal Ultrasound Treatment Response and Remission in Inflammatory Bowel Disease: Systematic Review and Expert Consensus Statement

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Crohn s and Colitis 2021 cited by 164

  16. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2019 cited by 216

  17. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives

    Authors: , , , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 153

  18. Biopsy and blood-based molecular biomarker of inflammation in IBD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce E. Sands, Marla C. Dubinsky, Jean‐Frédéric Colombel, Andrew Kasarskis, Mayte Suárez‐Fariñas - Gut 2022 cited by 118

  19. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group

    Authors: , , , , , , , , , , , - American Journal of Obstetrics and Gynecology 2019 cited by 348

  20. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lude Franke, Michel Georges, Jürgen Glas, Nicole L. Glazer, Stephen L. Guthery, Talin Haritunians, Nicholas K. Hayward, Jean‐Pierre Hugot, Gilles Jobin, Debby Laukens, Ian C. Lawrance, Marc Lémann, Arie Levine, Cécile Libioulle, Édouard Louis, Dermot McGovern, Mónica Milla, Grant W. Montgomery, Katherine I. Morley, Craig Mowat, Aylwin Ng, William G. Newman, Roel A. Ophoff, Laura Papi, Orazio Palmieri, Laurent Peyrin‐Biroulet, Julián Panés, Anne Phillips, Natalie J. Prescott, Deborah D. Proctor, Rebecca Roberts, Richard K. Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, L. Philip Schumm, Frank Seibold, Yashoda Sharma, Lisa A. Simms, Mark Seielstad, A. Hillary Steinhart, Stephan R. Targan, Leonard H. van den Berg, Morten Vatn, Hein W. Verspaget, Thomas D. Walters, Cisca Wijmenga, David C. Wilson, Harm-Jan Westra, Ramnik J. Xavier, Zhen Zhao, Cyriel Y. Ponsioen, Vibeke Andersen, Leif Törkvist, Maria Gazouli, Nicholas P. Anagnou, Tom H. Karlsen, Limas Kupčinskas, Jurgita Šventoraitytė, John Mansfield, Subra Kugathasan, Mark S. Silverberg, Jonas Halfvarson, Jerome I. Rotter, Christopher G. Mathew, Anne M. Griffiths, Richard B. Gearry, Tariq Ahmad, Steven R. Brant, Mathias Chamaillard and 13 more - Nature Genetics 2011 cited by 1,353

  21. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , - The American Journal of Gastroenterology 2021 cited by 197

  22. Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 160

  23. Fecal IgA Levels Are Determined by Strain-Level Differences in Bacteroides ovatus and Are Modifiable by Gut Microbiota Manipulation

    Authors: , , , , , , , , , , , , - Cell Host & Microbe 2020 cited by 226

  24. Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment

    Authors: , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2022 cited by 100